Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
11.55
+0.70 (6.45%)
At close: Sep 5, 2025, 4:00 PM
12.00
+0.45 (3.90%)
After-hours: Sep 5, 2025, 7:17 PM EDT

Elicio Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
1875580---
Upgrade
Market Cap Growth
193.83%-31.39%----
Upgrade
Enterprise Value
1805572---
Upgrade
Last Close Price
11.485.108.34---
Upgrade
PB Ratio
101.80-4.867.04---
Upgrade
P/TBV Ratio
102.18-7.04---
Upgrade
Debt / Equity Ratio
8.13-2.300.610.84-2.880.03
Upgrade
Quick Ratio
2.231.531.320.900.494.53
Upgrade
Current Ratio
2.281.801.681.560.554.67
Upgrade
Return on Equity (ROE)
-60013.19%-170157.38%-346.95%-1170.93%-430.76%-136.60%
Upgrade
Return on Assets (ROA)
-123.26%-101.64%-89.70%-79.16%-92.36%-68.96%
Upgrade
Return on Capital (ROIC)
-259.55%-170.31%-128.82%-123.12%-130.00%-80.83%
Upgrade
Earnings Yield
-29.14%-94.42%-43.93%---
Upgrade
FCF Yield
-18.75%-67.60%-40.89%---
Upgrade
Buyback Yield / Dilution
-45.98%-141.35%-1500.08%97.93%-42.39%-172.21%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q